Ethic Inc. Grows Stake in Corteva, Inc. $CTVA

Ethic Inc. boosted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 18.3% in the 4th quarter, Holdings Channel reports. The fund owned 91,808 shares of the company’s stock after acquiring an additional 14,225 shares during the quarter. Ethic Inc.’s holdings in Corteva were worth $6,154,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of CTVA. Activest Wealth Management grew its stake in Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock valued at $25,000 after acquiring an additional 200 shares in the last quarter. JPL Wealth Management LLC purchased a new stake in Corteva during the 3rd quarter valued at about $25,000. Redmont Wealth Advisors LLC purchased a new stake in Corteva during the 3rd quarter valued at about $29,000. Jackson Grant Investment Advisers Inc. grew its stake in Corteva by 90.6% during the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock valued at $30,000 after acquiring an additional 213 shares in the last quarter. Finally, KERR FINANCIAL PLANNING Corp purchased a new stake in Corteva during the 3rd quarter valued at about $33,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Insider Activity at Corteva

In related news, insider Brian Titus sold 8,311 shares of the stock in a transaction on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the transaction, the insider directly owned 8,090 shares of the company’s stock, valued at $619,289.50. This trade represents a 50.67% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.15% of the company’s stock.

Corteva Stock Performance

Shares of CTVA stock opened at $81.10 on Friday. The firm’s 50 day moving average price is $80.68 and its 200-day moving average price is $72.61. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.96 and a current ratio of 1.47. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63. The firm has a market cap of $54.24 billion, a P/E ratio of 47.70, a P/E/G ratio of 2.77 and a beta of 0.59.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The company had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts predict that Corteva, Inc. will post 3.67 EPS for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Shareholders of record on Monday, June 1st will be given a $0.18 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio is currently 42.35%.

Wall Street Analyst Weigh In

Several analysts recently issued reports on CTVA shares. Wells Fargo & Company upped their price objective on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, April 21st. Rothschild & Co Redburn upped their price objective on shares of Corteva from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Wednesday, April 29th. Berenberg Bank increased their price target on shares of Corteva from $68.00 to $78.00 and gave the company a “hold” rating in a research note on Thursday, March 26th. Jefferies Financial Group increased their price target on shares of Corteva from $95.00 to $97.00 in a research note on Thursday. Finally, BNP Paribas Exane increased their price target on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday. Thirteen investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $87.05.

Corteva News Roundup

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Royal Bank of Canada raised Corteva’s price target to $97 from $95 and kept an outperform rating, signaling confidence in roughly 20% upside from recent levels. RBC Capital adjusts Corteva price target to $97 from $95, maintains outperform rating
• Positive Sentiment: Jefferies also increased its target on Corteva to $97 from $95, reinforcing a bullish view on the stock’s longer-term valuation. Jefferies adjusts price target on Corteva to $97 from $95
• Neutral Sentiment: UBS raised its target to $90 from $88 but kept a neutral rating, suggesting limited near-term conviction despite modest upside potential. UBS Group AG price target raise
• Neutral Sentiment: Citigroup lifted its target to $85 from $83 and maintained a neutral rating, indicating some valuation support but no strong bullish call. Citigroup Inc. price target raise
• Neutral Sentiment: Corteva said CEO Chuck Magro and CFO David Johnson will speak at the BMO Global Farm to Market Conference on May 14, a routine investor-relations event with limited immediate impact. Corteva to Participate in BMO Global Farm to Market Conference
• Neutral Sentiment: BNP Paribas Exane nudged its target higher to $77 from $74 but still implied downside from the stock’s recent trading range, making it a mixed signal. BNP Paribas adjusts price target on Corteva to $77 from $74

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.